Antiviral Activity of Bay 41-4109 on Hepatitis B Virus in Humanized Alb-uPA/SCID Mice

Current treatments for HBV chronic carriers using interferon alpha or nucleoside analogues are not effective in all patients and may induce the emergence of HBV resistant strains. Bay 41-4109, a member of the heteroaryldihydropyrimidine family, inhibits HBV replication by destabilizing capsid assemb...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Brezillon, Nicolas, Brunelle, Marie-Noëlle, Massinet, Hélène, Giang, Eric, Lamant, Céline, DaSilva, Lucie, Berissi, Sophie, Belghiti, Jacques, Hannoun, Laurent, Puerstinger, Gherard, Wimmer, Eva, Neyts, Johan, Hantz, Olivier, Soussan, Patrick, Morosan, Serban, Kremsdorf, Dina
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Public Library of Science 2011
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3230577/
https://ncbi.nlm.nih.gov/pubmed/22162746
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0025096
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak